These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 16392439)
1. Glycated hemoglobin and liver disease in diabetes mellitus. Schnedl WJ; Wallner SJ; Piswanger C; Krause R; Lipp RW Wien Med Wochenschr; 2005 Sep; 155(17-18):411-5. PubMed ID: 16392439 [TBL] [Abstract][Full Text] [Related]
2. Fructosamine and Glycated Albumin and the Risk of Cardiovascular Outcomes and Death. Selvin E; Rawlings AM; Lutsey PL; Maruthur N; Pankow JS; Steffes M; Coresh J Circulation; 2015 Jul; 132(4):269-77. PubMed ID: 26022911 [TBL] [Abstract][Full Text] [Related]
3. Fructosamine and glycated hemoglobin as indices of glycemic control in patients with liver cirrhosis. Trenti T; Cristani A; Cioni G; Pentore R; Mussini C; Ventura E Ric Clin Lab; 1990; 20(4):261-7. PubMed ID: 2075378 [TBL] [Abstract][Full Text] [Related]
4. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring. Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672 [TBL] [Abstract][Full Text] [Related]
5. Plasma albumin concentration is a predictor of HbA1c among type 2 diabetic patients, independently of fasting plasma glucose and fructosamine. Rodríguez-Segade S; Rodríguez J; Mayan D; Camiña F Diabetes Care; 2005 Feb; 28(2):437-9. PubMed ID: 15677811 [No Abstract] [Full Text] [Related]
6. Frequency of HbA1c discordance in estimating blood glucose control. Cohen RM; Smith EP Curr Opin Clin Nutr Metab Care; 2008 Jul; 11(4):512-7. PubMed ID: 18542015 [TBL] [Abstract][Full Text] [Related]
7. Improvement of glycemic control in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. Monami M; Candido R; Pintaudi B; Targher G; Mannucci E; Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2539-2546. PubMed ID: 34158243 [TBL] [Abstract][Full Text] [Related]
8. Effects comparison between low glycemic index diets and high glycemic index diets on HbA1c and fructosamine for patients with diabetes: A systematic review and meta-analysis. Wang Q; Xia W; Zhao Z; Zhang H Prim Care Diabetes; 2015 Oct; 9(5):362-9. PubMed ID: 25524422 [TBL] [Abstract][Full Text] [Related]
9. Can plasma fructosamine substitute for glycated haemoglobin (HbA1c) estimation in the assessment of diabetic control? Malik M; Gill GV; Pugh RN; Bakir A; Hossain M Trop Doct; 2000 Apr; 30(2):74-6. PubMed ID: 10842549 [TBL] [Abstract][Full Text] [Related]
10. A comparison of fructosamine and HbA1c for home self-monitoring blood glucose levels in type 2 diabetes. Chen HS; Chen RL; Chang ZY; Li HD Zhonghua Yi Xue Za Zhi (Taipei); 2002 Apr; 65(4):151-5. PubMed ID: 12135193 [TBL] [Abstract][Full Text] [Related]
11. Importance of the Average Glucose Level and Estimated Glycated Hemoglobin in a Diabetic Patient with Hereditary Hemolytic Anemia and Liver Cirrhosis. Nakatani R; Murata T; Usui T; Moriyoshi K; Komeda T; Masuda Y; Kakita-Kobayashi M; Tagami T; Imashuku S; Kono S; Yamada K; Shimatsu A Intern Med; 2018 Feb; 57(4):537-543. PubMed ID: 29225250 [TBL] [Abstract][Full Text] [Related]
12. Hepatogenous diabetes: Is it time to separate it from type 2 diabetes? Orsi E; Grancini V; Menini S; Aghemo A; Pugliese G Liver Int; 2017 Jul; 37(7):950-962. PubMed ID: 27943508 [TBL] [Abstract][Full Text] [Related]
13. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma. Paroni R; Ceriotti F; Galanello R; Battista Leoni G; Panico A; Scurati E; Paleari R; Chemello L; Quaino V; Scaldaferri L; Lapolla A; Mosca A Clin Biochem; 2007 Dec; 40(18):1398-405. PubMed ID: 17919531 [TBL] [Abstract][Full Text] [Related]
14. The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring. Beck R; Steffes M; Xing D; Ruedy K; Mauras N; Wilson DM; Kollman C; Pediatr Diabetes; 2011 Dec; 12(8):690-5. PubMed ID: 21496193 [TBL] [Abstract][Full Text] [Related]
15. Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease. Zelnick LR; Batacchi ZO; Ahmad I; Dighe A; Little RR; Trence DL; Hirsch IB; de Boer IH Diabetes Care; 2020 Oct; 43(10):2379-2387. PubMed ID: 32788282 [TBL] [Abstract][Full Text] [Related]
16. Serum fructosamine versus glycosylated hemoglobin as an index of glycemic control, hospitalization, and infection in diabetic hemodialysis patients. Mittman N; Desiraju B; Fazil I; Kapupara H; Chattopadhyay J; Jani CM; Avram MM Kidney Int Suppl; 2010 Aug; (117):S41-5. PubMed ID: 20671744 [TBL] [Abstract][Full Text] [Related]
17. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence. Sany D; Elshahawy Y; Anwar W Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348 [TBL] [Abstract][Full Text] [Related]
18. Assessing glycaemic control in diabetes: relationships between fructosamine and HbA1C. Braatvedt GD; Drury PL; Cundy T N Z Med J; 1997 Dec; 110(1057):459-62. PubMed ID: 9451409 [TBL] [Abstract][Full Text] [Related]
19. 2019 John Insall Award: Fructosamine is a better glycaemic marker compared with glycated haemoglobin (HbA1C) in predicting adverse outcomes following total knee arthroplasty: a prospective multicentre study. Shohat N; Tarabichi M; Tan TL; Goswami K; Kheir M; Malkani AL; Shah RP; Schwarzkopf R; Parvizi J Bone Joint J; 2019 Jul; 101-B(7_Supple_C):3-9. PubMed ID: 31256656 [TBL] [Abstract][Full Text] [Related]
20. Home testing of fructosamine improves glycemic control in patients with diabetes. Edelman SV; Bell JM; Serrano RB; Kelemen D Endocr Pract; 2001; 7(6):454-8. PubMed ID: 11747282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]